UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13D

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)*

GOLDEN MATRIX GROUP, INC.

(Name of Issuer)

Common Stock, $0.00001 par value per share

(Title of Class of Securities)

381098300

(CUSIP Number)

Zoran Milošević

Bulevar Mihajla Pupina 108, Belgrade, Serbia

+381113015309

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

October 14, 2024

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 381098300 Schedule 13D/A Page 2 of 7

1.	Name of Reporting Person Aleksandar Milovanović
2.	Check the Appropriate Box if a Member of a Group. (a) ☒. (b) ☐.
3.	SEC Use Only
4.	Source of Funds SC
5.	Check if Disclosure of Legal Proceedings is Required Pursuant to Item 2(d) or 2(e). ☐
6.	Citizenship or Place of Organization Serbia

Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power Without Series B Preferred Stock voting: 77,757,345 shares of Common Stock(1)* With Series B Preferred Stock (voting only): 83,778,911 shares of Common Stock(2)*
	8.	Shared Voting Power -0- shares of Common Stock*
	9.	Sole Dispositive Power 77,757,345 shares of Common Stock(1)*
	10.	Shared Dispositive Power -0- shares of Common Stock

11.	Aggregate Amount Beneficially Owned by Each Reporting Person Without Series B Preferred Stock Voting: 77,757,345 shares of Common Stock(1)* With Series B Preferred Stock (voting only): 83,778,911 shares of Common Stock(2)*
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares. ☐
13.	Percent of Class Represented by Amount in Row (11) Without Series B Preferred Stock Voting: 60.2%(1)(3)* With Series B Preferred Stock (voting only): 58.3%(2)(4)*
14.	Type of Reporting Person IN

___________________

(1)	Includes 850 shares of common stock issuable upon conversion of 850 shares of Series C Voting Preferred Stock held by Mr. Milovanović. Includes shares of common stock issuable upon conversion of the Convertible Note, discussed and defined below in Item 3.
(2)	Includes the voting rights of the 850 shares of Series C Voting Preferred Stock held by Mr. Milovanović, which each vote 7,500 voting shares, or 6,375,000 voting shares in aggregate.
(3)	Based solely for the purposes of such calculation on 128,782,965 total common shares (together with 850 shares of common stock issuable upon conversion of the Series C Voting Preferred Stock), the number of shares outstanding as of October 15, 2024, as confirmed by the Issuer’s Transfer Agent.
(4)	Based solely for the purposes of such calculation on a total of 143,782,965 total voting shares including 128,782,965 total common shares, the number of shares outstanding as of October 15, 2024, as confirmed by the Issuer’s Transfer Agent, 7,500,000 shares voted by the Series B Voting Preferred Stock and 7,500,000 shares voted by the Series C Voting Preferred Stock).

* Does not include shares of Common Stock held by the Separately Filing Group Members (as defined below in Item 2). The Reporting Persons (as defined below in Item 2) believe that they and the Separately Filing Group together as a “group” may be deemed to collectively beneficially own in the aggregate 121,654,100 total voting shares or 84.6% of the Issuer’s total voting shares, as of October 15, 2024.

CUSIP No. 381098300 Schedule 13D/A Page 3 of 7

1.	Name of Reporting Person Zoran Milošević
2.	Check the Appropriate Box if a Member of a Group. (a) ☒. (b) ☐.
3.	SEC Use Only
4.	Source of Funds SC
5.	Check if Disclosure of Legal Proceedings is Required Pursuant to Item 2(d) or 2(e). ☐
6.	Citizenship or Place of Organization Serbia

Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power Without Series B Preferred Stock voting: 8,757,764 shares of Common Stock(1)* With Series B Preferred Stock (voting only): 9,507,664 shares of Common Stock(2)*
	8.	Shared Voting Power -0- shares of Common Stock*
	9.	Sole Dispositive Power 8,757,764 shares of Common Stock(1)*
	10.	Shared Dispositive Power -0- shares of Common Stock*

11.	Aggregate Amount Beneficially Owned by Each Reporting Person Without Series B Preferred Stock Voting: 8,757,764 shares of Common Stock(1)* With Series B Preferred Stock (voting only): 9,507,664 shares of Common Stock(2)*
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares. ☐
13.	Percent of Class Represented by Amount in Row (11) Without Series B Preferred Stock Voting: 6.8%(1)(3)* With Series B Preferred Stock (voting only): 6.6%(2)(4)*
14.	Type of Reporting Person IN

___________________

(1)	Includes 100 shares of common stock issuable upon conversion of 100 shares of Series C Voting Preferred Stock held by Mr. Milošević.
(2)	Includes the voting rights of the 100 shares of Series C Voting Preferred Stock held by Mr. Milošević, which each vote 7,500 voting shares, or 750,000 voting shares in aggregate.
(3)	Based solely for the purposes of such calculation on 128,782,965 total common shares (together with 100 shares of common stock issuable upon conversion of the Series C Voting Preferred Stock), the number of shares outstanding as of October 15, 2024, as confirmed by the Issuer’s Transfer Agent.
(4)	Based solely for the purposes of such calculation on a total of 143,782,965 total voting shares (including 128,782,965 total common shares, the number of shares outstanding as of October 15, 2024, as confirmed by the Issuer’s Transfer Agent, 7,500,000 shares voted by the Series B Voting Preferred Stock and 7,500,000 shares voted by the Series C Voting Preferred Stock).

* Does not include shares of Common Stock held by the Separately Filing Group Members (as defined below in Item 2). The Reporting Persons (as defined below in Item 2) believe that they and the Separately Filing Group together as a “group” may be deemed to collectively beneficially own in the aggregate 121,654,100 total voting shares or 84.6% of the Issuer’s total voting shares, as of October 15, 2024.

CUSIP No. 381098300 Schedule 13D/A Page 4 of 7

1.	Name of Reporting Person Snežana Božović
2.	Check the Appropriate Box if a Member of a Group. (a) ☒. (b) ☐.
3.	SEC Use Only
4.	Source of Funds SC
5.	Check if Disclosure of Legal Proceedings is Required Pursuant to Item 2(d) or 2(e). ☐
6.	Citizenship or Place of Organization Serbia

Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power Without Series B Preferred Stock voting: 4,368,013 shares of Common Stock(1)* With Series B Preferred Stock (voting only): 4,742,963 shares of Common Stock(2)*
	8.	Shared Voting Power -0- shares of Common Stock*
	9.	Sole Dispositive Power 4,368,013 shares of Common Stock(1)*
	10.	Shared Dispositive Power -0- shares of Common Stock

11.	Aggregate Amount Beneficially Owned by Each Reporting Person Without Series B Preferred Stock Voting: 4,368,013 shares of Common Stock(1)* With Series B Preferred Stock (voting only): 4,742,963 shares of Common Stock(2)*
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares. ☐
13.	Percent of Class Represented by Amount in Row (11) Without Series B Preferred Stock Voting: 3.4%(1)(3)* With Series B Preferred Stock (voting only): 3.3%(2)(4)*
14.	Type of Reporting Person IN

___________________

(1)	Includes 50 shares of common stock issuable upon conversion of 50 shares of Series C Voting Preferred Stock held by Ms. Božović.
(2)	Includes the voting rights of the 50 shares of Series C Voting Preferred Stock held by Ms. Božović, which each vote 7,500 voting shares, or 375,000 voting shares in aggregate.
(3)	Based solely for the purposes of such calculation on 128,782,965 total common shares (together with 50 shares of common stock issuable upon conversion of the Series C Voting Preferred Stock), the number of shares outstanding as of October 15, 2024, as confirmed by the Issuer’s Transfer Agent.
(4)	Based solely for the purposes of such calculation on a total of 143,782,965 total voting shares (including 128,782,965 total common shares, the number of shares outstanding as of October 15, 2024, as confirmed by the Issuer’s Transfer Agent, 7,500,000 shares voted by the Series B Voting Preferred Stock and 7,500,000 shares voted by the Series C Voting Preferred Stock).

* Does not include shares of Common Stock held by the Separately Filing Group Members (as defined below in Item 2). The Reporting Persons (as defined below in Item 2) believe that they and the Separately Filing Group together as a “group” may be deemed to collectively beneficially own in the aggregate 121,654,100 total voting shares or 84.6% of the Issuer’s total voting shares, as of October 15, 2024.

CUSIP No. 381098300 Schedule 13D/A Page 5 of 7

EXPLANATORY NOTE

This Amendment No. 3 (the “Amendment”) amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the “Commission”) on April 11, 2024, by (1) Aleksandar Milovanović (“Milovanović”), an individual; (2) Zoran Milošević (“Milošević”), an individual; and (3) Snežana Božović (“Božović”), an individual (collectively, the “Reporting Persons” or the “Sellers”), as amended by Amendment No. 1 thereto filed with the Commission on August 28, 2024 and Amendment No. 2 thereto filed with the Commission on October 3, 2024 (the Schedule 13D as amended to date, the “Schedule 13D”).

As used in this Amendment:

· “Common Stock” means the common stock of the Issuer; and

· “Issuer” or “Company” means Golden Matrix Group, Inc.

Other capitalized terms used but not otherwise defined in this Amendment have the meanings ascribed to such terms in the Schedule 13D. Except as expressly amended and supplemented by this Amendment, the Schedule 13D is not amended or supplemented in any respect, and the disclosures set forth in the Schedule 13D, other than as amended herein are incorporated by reference herein. This Amendment should be read together with the Schedule 13D.

Item 2. Identity and Background

The last paragraph of Item 2 of the Schedule 13D is amended and restated to read as follows:

The Reporting Persons do not assume responsibility for the information contained in the Schedule 13Ds filed by the Separately Filing Group Members, except to the extent such information has been provided by the Reporting Persons. Based on information provided by the Separately Filing Group Members, the Reporting Persons believe that they and the Separately Filing Group Members together as a “group” may be deemed to collectively beneficially own in the aggregate 121,654,100 total voting shares or 84.6% of the Issuer’s total voting shares, as of October 15, 2024. The Reporting Persons expressly disclaim beneficial ownership of any securities beneficially owned or acquired by the Separately Filing Group Members.

Item 3. Source and Amount of Funds or Other Consideration

Item 3 is hereby amended and supplemented by adding the following at the end thereof:

Post-Closing Contingent Stock Consideration

As previously disclosed in the Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission (the “SEC”) on April 9, 2024, effective on April 1, 2024, the Issuer closed the transactions contemplated by that certain Sale and Purchase Agreement of Share Capital dated January 11, 2023 (as amended and restated from time to time, the “Purchase Agreement”) with Milovanović, Milošević and Božović (collectively, the “Sellers”), the former owners of Meridian Tech Društvo Sa Ograničenom Odgovornošću Beograd, a private limited company formed and registered in and under the laws of the Republic of Serbia (“Meridian Serbia”); Društvo Sa Ograničenom Odgovornošću “Meridianbet” Društvo Za Proizvodnju, Promet Roba I Usluga, Export Import Podgorica, a private limited company formed and registered in and under the laws of Montenegro; Meridian Gaming Holdings Ltd., a company formed and registered in the Republic of Malta; and Meridian Gaming (Cy) Ltd, a company formed and registered in the republic of Cyprus (collectively, the “Meridian Companies”).

CUSIP No. 381098300 Schedule 13D/A Page 6 of 7

As part of the consideration for the acquisition, the Issuer agreed to pay the Sellers 5,000,000 restricted shares of common stock (the “Contingent Shares”) which were due to the Sellers within five business days following the Determination Date (defined below) if (and only if) the Company determined that each of the Post-Closing Conditions (defined below) were met on such Determination Date. For purposes of the foregoing, the “Determination Date” means the date that was six months after the closing date of the Purchase Agreement (October 9, 2024) and the “Contingent Post-Closing Conditions” were as follows: the Sellers and their affiliates were not then in default in any of their material obligations, covenants or representations under the Purchase Agreement, any of the transaction documents, or any other agreement with the Company beyond any applicable cure periods therein, as confirmed by Sellers in a signed writing delivered to the Company and verified by the Company within five business days thereafter.

On October 14, 2024, the Company determined that the Contingent Post-Closing Conditions were met and issued the 5,000,000 Contingent Shares to the Sellers, of which 4,250,000 shares were issued to Milovanović; 500,000 shares were issued to Milošević; and 250,000 shares were issued to Božović.

Item 5. Interest in Securities of the Issuer

The information provided in Items 3 and 4 of this Schedule 13D is incorporated by reference herein.

(a) and (b) The aggregate number of shares of Common Stock beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the voting thereof, shared power to vote or to direct the voting thereof, sole power to dispose or to direct the disposition thereof, or shared power to dispose or to direct the disposition thereof, are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D and are incorporated herein by this reference thereto.

Item 2 and Item 4 of this Schedule 13D, which identifies the Reporting Persons and the Separately Filing Group Members and discloses the voting provisions of the Voting Agreement, is incorporated herein by this reference thereto.

Due to the terms of the Voting Agreement, the Reporting Persons and Separately Filing Group Members may be deemed a group for the purposes of Section 13(d)(3) of the Exchange Act. The security interests reported in this Schedule 13D do not include security interests owned by the Separately Filing Group Members. The Separately Filing Group Members will file separate Schedule 13Ds reporting beneficial ownership of the Issuer’s securities. The Reporting Persons assume no responsibility for the information contained in such Schedule 13Ds or any amendment thereto. The Separately Filing Group Members and the Reporting Persons may be deemed to collectively beneficially own in the aggregate 121,654,100 total voting shares or 83.8% of the Issuer’s total voting shares, as of October 15, 2024.

(c) The information in Item 3 is incorporated by reference into this Item 5(c).

(d) No other person has the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of the securities beneficially owned by the Reporting Persons.

(e) N/A.

CUSIP No. 381098300 Schedule 13D/A Page 7 of 7

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

October 15, 2024

/s/ Aleksandar Milovanović

Aleksandar Milovanović

October 15, 2024

/s/ Zoran Milošević

Zoran Milošević

October 15, 2024

/s/ Snežana Božović

Snežana Božović